Melatonin

A low daytime melatonin result can be entirely normal. The hormone usually rises during your biological night, so a number without its collection time and your recent sleep and light history is hard to interpret.

A single blood measurement remains exploratory for prevention and healthy aging. It has no validated target for those purposes, and testing hasn't been shown to improve long-term health outcomes. Serial evening measurements have a different, established use: identifying the timing of your body's internal clock.

A Hormone Made for the Dark

Your body makes melatonin from tryptophan. Tryptophan is an amino acid supplied by food. The pineal gland in your brain produces most of the melatonin responsible for the nightly rise in your bloodstream.

Your internal clock controls that rise, and light reaching your eyes helps set the clock. Light during the biological night can also suppress melatonin directly. Darkness permits the nightly rise, but sitting in a dark room during the day doesn't automatically switch production on. The timing and size of the peak vary with your sleep schedule, light exposure, age, and individual biology.

What the Blood Number Represents

This test measures total melatonin in serum or plasma from a blood draw, including hormone bound to proteins and hormone circulating freely. The method is liquid chromatography-tandem mass spectrometry (LC-MS/MS). It separates and identifies melatonin before measuring its concentration. Results are reported in picograms per milliliter (pg/mL).

The result describes the concentration at that moment. Production, release, and removal from the bloodstream all affect it. A single value cannot establish the height of your nighttime peak, total overnight production, or when the evening rise began.

How Levels Change With Age

Nighttime concentrations are often highest in early childhood and fall through adolescence. In one serum study using an antibody-based assay, average nighttime levels in late adolescence were about 80% lower than in early childhood. That comparison describes differences between age groups; its absolute measurements shouldn't be transferred directly to LC-MS/MS results.

Average nighttime levels are also lower in many studies of older adults, though individual results vary widely. A lower value doesn't establish that you're aging faster, and there is no validated annual rate of decline against which to judge your own results.

Blood Sugar and Type 2 Diabetes

One prospective study found a higher diabetes risk in adults whose overnight melatonin marker fell in the lowest fifth, compared with the remaining participants. The study measured 6-sulfatoxymelatonin in first-morning urine, adjusted for urine creatinine. This is a breakdown product used to estimate nighttime secretion, a different measurement from melatonin in blood.

The association persisted after adjustment for several other risk factors, but it doesn't show that low melatonin caused diabetes or that a daytime blood result predicts your risk. Human genetic research also connects melatonin receptor signaling with insulin release and diabetes. That evidence points to a role for timing and hormone signaling, without establishing that a higher circulating concentration is always healthier.

Other Disease Associations

• Brain disorders: studies of Alzheimer's disease often report reduced nighttime blood melatonin or disrupted rhythms. Findings in Parkinson's disease are mixed, including reports of higher concentrations. Sampling time, medications, and measurement methods differ across studies. A single blood value has no established role in diagnosing these disorders or predicting whether you'll develop them.
• Kidney disease: a study of chronic kidney failure found lower melatonin and a disrupted daily pattern in saliva. Saliva reflects the freely circulating fraction, so those results cannot be treated as measurements of total blood melatonin. Kidney disease can affect hormone rhythms and clearance, but a blood melatonin result doesn't diagnose kidney failure.
• Cancer: some studies have associated lower overnight urinary 6-sulfatoxymelatonin with greater breast cancer risk. These findings concern a urine breakdown product and don't establish a cancer-screening role for blood melatonin.

Sleep Timing Problems

The dim light melatonin onset marks when your evening melatonin rise begins under controlled lighting. It is a well-established measure of internal clock timing. Finding it requires a series of evening saliva or blood samples, interpreted alongside your sleep history.

In a study of 56 people evaluated for delayed sleep phase, serial saliva testing with an antibody-based assay identified about 90% of clinically diagnosed cases and correctly classified about 74% of those without the diagnosis. Those figures describe that particular study and protocol. They don't describe the accuracy of a single blood draw, which cannot locate the onset.

When Results Can Be Misleading

• Collection time and sleep schedule: daytime values are usually low. Shift work, jet lag, and irregular sleep can change where a blood draw falls within your daily rhythm.
• Light exposure: ordinary indoor light can suppress or delay the evening rise. The effect depends on brightness, wavelength, duration, prior light exposure, and individual sensitivity; there isn't one light threshold that applies to everyone.
• Melatonin supplements: a recent dose can raise blood concentrations far above your natural nighttime peak. The assay measures supplemental and naturally produced melatonin together, so the result cannot separate the two sources.
• Medications and alcohol: atenolol and some other beta-blockers suppress nighttime production. Small human studies also found suppression after alcohol and certain anti-inflammatory pain relievers. These effects can change the result without establishing an underlying sleep or hormone disorder.
• Surgery and serious illness: these can alter the timing and size of the rhythm. During severe illness, organ dysfunction and medications may produce different patterns, so the result may not represent your usual physiology.

LC-MS/MS reduces the cross-reactions that can affect antibody-based assays, but measurements still become less precise near the method's lower measuring limit. Sample processing, storage, and laboratory calibration also matter. An undetectable result means the concentration was below the method's detection capability at that moment; it doesn't establish that your body makes no melatonin.

What Serial Results Can Show

An early-morning serum study found that individual levels were relatively reproducible over one to five years when collection time and season were matched. It studied older men and used an antibody-based assay. That supports some uses in population research, but it doesn't establish how much change is medically meaningful for you or validate serial testing as a measure of aging.